Yazdian Fatemeh Askari, Samak Matin Mojaveri, Larijani Amirhossein, Ashoobi Mohammad Taghi, Kharaqani Mohadese, Ghezel Mohammad Amin, Barabadi Zahra, Vojoudi Elham
Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Department of Internal Medicine, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Stem Cell Rev Rep. 2025 May 24. doi: 10.1007/s12015-025-10872-1.
Liver diseases, such as hepatitis, cirrhosis, and liver cancer, pose significant public health challenges, ranking as the twelfth leading cause of death globally. Given the liver's critical functions in metabolism, detoxification, and biosynthesis, its impairment can lead to severe consequences, often resulting in end-stage liver failure. Although liver transplantation is regarded as the definitive intervention for advanced liver disease, factors such as a shortage of donors and potential surgical complications necessitate the investigation of non-surgical regenerative medicine alternatives. This manuscript provides a comprehensive review of innovative non-surgical therapies aimed at liver regeneration, with an emphasis on both cell-based and cell-free approaches. It examines the contributions of various stem cell populations, including mesenchymal stem cells, hematopoietic stem cells, and induced pluripotent stem cells, in facilitating liver repair through mechanisms of differentiation and paracrine signaling. Furthermore, it explores the therapeutic potential of exosomes and conditioned media derived from stem cells as biotherapeutic agents in the context of regenerative medicine. By elucidating the mechanisms that underpin liver regeneration, this study aspires to inform the development of effective therapeutic strategies to address liver diseases and slow their progression. By elucidating the underlying mechanisms of liver regeneration, this study aims to contribute to the development of effective therapeutic strategies to address liver diseases and slow their progression.
肝脏疾病,如肝炎、肝硬化和肝癌,对公共卫生构成了重大挑战,在全球范围内是第十二大致死原因。鉴于肝脏在代谢、解毒和生物合成方面的关键功能,其损伤会导致严重后果,常常引发终末期肝衰竭。尽管肝移植被视为晚期肝病的决定性干预措施,但诸如供体短缺和潜在手术并发症等因素使得有必要研究非手术再生医学替代方案。本手稿全面综述了旨在促进肝脏再生的创新性非手术疗法,重点关注基于细胞和无细胞方法。它研究了各种干细胞群体,包括间充质干细胞、造血干细胞和诱导多能干细胞,通过分化和旁分泌信号传导机制促进肝脏修复的作用。此外,它还探讨了干细胞来源的外泌体和条件培养基作为再生医学背景下生物治疗剂的治疗潜力。通过阐明肝脏再生的基础机制,本研究旨在为制定有效的治疗策略提供信息,以应对肝脏疾病并减缓其进展。通过阐明肝脏再生的潜在机制,本研究旨在为开发有效的治疗策略做出贡献,以应对肝脏疾病并减缓其进展。